Discover 859 paid clinical trials in Tuscaloosa, Alabama. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 859
Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI
for
HER2-positive Breast Cancer
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: Female
Age: 18+
Code: NCT04332588
Phase1, Recruiting
Phase II Panitumumab-IRDye800 in Head & Neck Cancer
for
Head and Neck Cancer
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT04511078
Phase2, Recruiting
Stroke Thrombectomy and Aneurysm Registry
for
Stroke, Thromboses, Intracranial, Aneurysm, Brain
Location: Birmingham AL, Atlanta GA, Memphis TN, New Orleans LA,
Sponsor: Medical University of South Carolina
Sex: All
Age: 1 - 70+
Code: NCT04994756
Recruiting
A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial
Get alerts for new trials in your area by subscribing now
American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry
for
Pancreatic Cancer
Location: Birmingham AL, Augusta GA, Spartanburg SC,
Sponsor: University of Louisville
Sex: All
Age: 18+
Code: NCT02674100
Recruiting
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
for
Dravet Syndrome
Location: Birmingham AL, Little Rock AR, Louisville KY,
Sponsor: Epygenix
Sex: All
Age: 2+
Code: NCT04462770
Phase3, Recruiting
Rett Syndrome Registry
for
Rett Syndrome, Rett Syndrome, Atypical, Genetic Disease,
Location: Birmingham AL, Nashville TN, Greenwood SC, St Louis MO,
Sponsor: International Rett Syndrome Foundation
Sex: All
Age: 0 - 70+
Code: NCT05432349
Recruiting
A Study to Test Whether Spesolimab Helps People With a Skin Condition Called Pyoderma Gangrenosum
for
Pyoderma Gangrenosum
Location: Birmingham AL, New Orleans LA, Tampa FL,
Sponsor: LEO Pharma
Sex: All
Age: 18+
Code: NCT06624670
Phase3, Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
for
Neoplasms
Location: Birmingham AL, Atlanta GA, Nashville TN, Greenville SC,
Sponsor: Celgene
Sex: All
Age: 0+
Code: NCT03435796
Phase2, Phase3, Recruiting
Neurophysiological, Behavioral, and Cognitive Networks in Movement Disorders
for
Movement Disorders
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT04061135
Recruiting
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
for
Barretts Esophagus With Dysplasia, Barrett Esophagus,
Location: Birmingham AL, St Louis MO, Jacksonville FL,
Sponsor: University of Colorado, Denver
Sex: All
Age: 18 - 70+
Code: NCT05753748
Recruiting
Combination Therapy for the Treatment of Diffuse Midline Gliomas
for
Diffuse Intrinsic Pontine Glioma,
Location: Birmingham AL, St Louis MO, Indianapolis IN, Durham NC,
Sponsor: University of California, San Francisco
Sex: All
Age: 2 - 39
Code: NCT05009992
Phase2, Recruiting
Evaluate the Safety and Efficacy of Subcutaneous Siplizumab in the Treatment of Hidradenitis Suppurativa.
for
Hidradenitis Suppurativa
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18+
Code: NCT06326476
Early_phase1, Recruiting
DALY II USA/ MB-CART2019.1 for DLBCL
for
Refractory Diffuse Large B Cell Lymphoma (DLBCL),
Location: Birmingham AL, Atlanta GA, Nashville TN, Augusta GA,
Sponsor: Miltenyi Biomedicine GmbH
Sex: All
Age: 18+
Code: NCT04792489
Phase2, Recruiting
Denosumab for Type 1 Diabetes
for
Type 1 Diabetes
Location: Birmingham AL, Indianapolis IN, Duarte CA
Sponsor: City of Hope Medical Center
Sex: All
Age: 18 - 50
Code: NCT06524960
Phase1, Phase2, Recruiting
A Study of RM-718 in Healthy Subjects and Patients With MC4R Pathway Impairment
for
Hypothalamic Obesity, Prader-Willi Syndrome, PWS
Location: Birmingham AL, Nashville TN, Chicago IL, Boston MA,
Sponsor: Rhythm Pharmaceuticals, Inc.
Sex: All
Age: 12 - 65
Code: NCT06239116
Phase1, Phase2, Recruiting
New
Trial of Selumetinib and Bromodomain Inhibitor With Durvalumab for Sarcomas
for
MPNST, NF1, Sarcoma
Location: Birmingham AL
Sponsor: University of Alabama at Birmingham
Sex: All
Age: 18 - 70+
Code: NCT05253131
Phase2, Recruiting
A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
for
Recurrent Childhood Acute Myeloid Leukemia,
Location: Birmingham AL, Atlanta GA, Memphis TN, St Louis MO,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 18
Code: NCT06247787
Phase1, Recruiting
Streamlined Treatment of Pulmonary Exacerbations in Pediatrics
for
Cystic Fibrosis
Location: Birmingham AL, Atlanta GA, St Louis MO, Charleston SC,
Sponsor: University of Washington, the Collaborative Health Studies Coordinating Center